TokenPost topic
1 TokenPost story is tagged SERB Pharmaceuticals. The newest appear first.
License revenue included part of a €110 million upfront payment for Idefirix rights in Europe and the MENA region. Basic and diluted earnings per share were negative SEK 1.75.
Nov 12, 2026, 10:31 PM EST · Business
